227 related articles for article (PubMed ID: 23898841)
1. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.
Grant SS; Kawate T; Nag PP; Silvis MR; Gordon K; Stanley SA; Kazyanskaya E; Nietupski R; Golas A; Fitzgerald M; Cho S; Franzblau SG; Hung DT
ACS Chem Biol; 2013 Oct; 8(10):2224-34. PubMed ID: 23898841
[TBL] [Abstract][Full Text] [Related]
2. Targeting Phenotypically Tolerant Mycobacterium tuberculosis.
Gold B; Nathan C
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28233509
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
[TBL] [Abstract][Full Text] [Related]
4. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
Gold B; Warrier T; Nathan C
Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model.
Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA
Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471
[TBL] [Abstract][Full Text] [Related]
6. A Novel Small-Molecule Inhibitor of the
Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
[TBL] [Abstract][Full Text] [Related]
7. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
[TBL] [Abstract][Full Text] [Related]
8. Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells.
Alumasa JN; Manzanillo PS; Peterson ND; Lundrigan T; Baughn AD; Cox JS; Keiler KC
ACS Infect Dis; 2017 Sep; 3(9):634-644. PubMed ID: 28762275
[TBL] [Abstract][Full Text] [Related]
9. Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis.
Sarathy J; Dartois V; Dick T; Gengenbacher M
Antimicrob Agents Chemother; 2013 Apr; 57(4):1648-53. PubMed ID: 23335744
[TBL] [Abstract][Full Text] [Related]
10. Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an
de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866874
[TBL] [Abstract][Full Text] [Related]
11. Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.
Early J; Ollinger J; Darby C; Alling T; Mullen S; Casey A; Gold B; Ochoada J; Wiernicki T; Masquelin T; Nathan C; Hipskind PA; Parish T
ACS Infect Dis; 2019 Feb; 5(2):272-280. PubMed ID: 30501173
[TBL] [Abstract][Full Text] [Related]
12. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R
J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224
[TBL] [Abstract][Full Text] [Related]
13. Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.
Sarathy JP; Via LE; Weiner D; Blanc L; Boshoff H; Eugenin EA; Barry CE; Dartois VA
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203492
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
15. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.
Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA
mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524
[TBL] [Abstract][Full Text] [Related]
16. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
Goldman RC
Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
[TBL] [Abstract][Full Text] [Related]
17. Identification and development of novel indazole derivatives as potent bacterial peptidoglycan synthesis inhibitors.
Malapati P; Krishna VS; Dharmarajan S
Int J Mycobacteriol; 2018; 7(1):76-83. PubMed ID: 29516890
[TBL] [Abstract][Full Text] [Related]
18. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
19. Selective killing of nonreplicating mycobacteria.
Bryk R; Gold B; Venugopal A; Singh J; Samy R; Pupek K; Cao H; Popescu C; Gurney M; Hotha S; Cherian J; Rhee K; Ly L; Converse PJ; Ehrt S; Vandal O; Jiang X; Schneider J; Lin G; Nathan C
Cell Host Microbe; 2008 Mar; 3(3):137-45. PubMed ID: 18329613
[TBL] [Abstract][Full Text] [Related]
20. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
